AtaiBeckley Inc.
BPL-003
treatment-resistant depression
Countdown
177days
Phase 2 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 2 trial results for BPL-003 in treatment-resistant depression are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“Phase 2a Part 4 (two‑dose induction + SSRIs) cohort initial data on track for Q4 2026.”